Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Jaguar Health's Enterprise Value is $43.05 Mil.
Jaguar Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-34.06 Mil. Therefore, Jaguar Health's EV-to-EBIT ratio for today is -1.26.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Jaguar Health's Enterprise Value is $43.05 Mil.
Jaguar Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was $-31.61 Mil. Therefore, Jaguar Health's EV-to-EBITDA ratio for today is -1.36.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Jaguar Health's Enterprise Value is $43.05 Mil.
Jaguar Health's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $10.14 Mil. Therefore, Jaguar Health's EV-to-Revenue ratio for today is 4.25.
Jaguar Health Enterprise Value Historical Data
The historical data trend for Jaguar Health's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Jaguar Health's Enterprise Value
For the Biotechnology subindustry, Jaguar Health's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jaguar Health's Enterprise Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Jaguar Health's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Jaguar Health's Enterprise Value falls into.
Jaguar Health Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Jaguar Health's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jaguar Health (NAS:JAGX) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Jaguar Health's current Enterprise Value is $43.05 Mil.
Jaguar Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-34.06 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Jaguar Health's current Enterprise Value is $43.05 Mil.
Jaguar Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-31.61 Mil.
Jaguar Health's current Enterprise Value is $43.05 Mil.
Jaguar Health's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $10.14 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jaguar Health Enterprise Value Related Terms
Thank you for viewing the detailed overview of Jaguar Health's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Jaguar Health (Jaguar Health) Business Description
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments-human health and animal health. The company generates the majority of its revenue from the Human Health segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
JAGX has been successfully added to your 